Milestone Scientific (MLSS) Competitors $0.78 -0.07 (-8.17%) (As of 03:46 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends MLSS vs. LUNG, ELMD, CATX, DRTS, PROF, SKIN, KRMD, SGHT, LAKE, and BWAYShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Pulmonx (LUNG), Electromed (ELMD), Perspective Therapeutics (CATX), Alpha Tau Medical (DRTS), Profound Medical (PROF), Beauty Health (SKIN), KORU Medical Systems (KRMD), Sight Sciences (SGHT), Lakeland Industries (LAKE), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Pulmonx Electromed Perspective Therapeutics Alpha Tau Medical Profound Medical Beauty Health KORU Medical Systems Sight Sciences Lakeland Industries BrainsWay Milestone Scientific (NYSE:MLSS) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, community ranking, valuation, media sentiment, institutional ownership, risk, earnings and dividends. Do analysts rate MLSS or LUNG? Milestone Scientific presently has a consensus target price of $1.25, indicating a potential upside of 47.08%. Pulmonx has a consensus target price of $12.75, indicating a potential upside of 107.99%. Given Pulmonx's higher probable upside, analysts plainly believe Pulmonx is more favorable than Milestone Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulmonx 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, MLSS or LUNG? Milestone Scientific has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Do insiders & institutionals have more ownership in MLSS or LUNG? 5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by insiders. Comparatively, 5.7% of Pulmonx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in MLSS or LUNG? Pulmonx received 31 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 44.00% of users gave Pulmonx an outperform vote while only 2.60% of users gave Milestone Scientific an outperform vote. CompanyUnderperformOutperformMilestone ScientificOutperform Votes22.60%Underperform Votes7597.40% PulmonxOutperform Votes3344.00% Underperform Votes4256.00% Is MLSS or LUNG more profitable? Milestone Scientific has a net margin of -52.01% compared to Pulmonx's net margin of -72.01%. Pulmonx's return on equity of -53.88% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% Pulmonx -72.01%-53.88%-33.47% Does the media prefer MLSS or LUNG? In the previous week, Pulmonx had 8 more articles in the media than Milestone Scientific. MarketBeat recorded 9 mentions for Pulmonx and 1 mentions for Milestone Scientific. Pulmonx's average media sentiment score of 0.25 beat Milestone Scientific's score of 0.00 indicating that Pulmonx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pulmonx 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, MLSS or LUNG? Milestone Scientific has higher earnings, but lower revenue than Pulmonx. Milestone Scientific is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$8.88M7.46-$6.93M-$0.07-12.14Pulmonx$79.30M3.05-$60.84M-$1.47-4.17 SummaryPulmonx beats Milestone Scientific on 11 of the 18 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$66.20M$9.79B$5.14B$19.67BDividend YieldN/A1.35%4.81%3.51%P/E Ratio-12.1420.33135.3143.76Price / Sales7.4632.331,215.7417.40Price / CashN/A22.3940.5821.73Price / Book7.735.754.885.46Net Income-$6.93M$182.72M$118.89M$987.68M7 Day Performance-0.01%-2.91%16.99%-2.32%1 Month Performance31.85%4.95%16.58%0.63%1 Year Performance47.81%-5.77%35.26%16.39% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific1.7973 of 5 stars$0.78-8.2%$1.25+60.2%+46.8%$60.80M$8.88M-11.1530LUNGPulmonx2.9259 of 5 stars$6.12+0.3%$12.75+108.3%-50.2%$241.67M$79.30M-4.15250ELMDElectromedN/A$28.170.0%N/A+171.1%$238.26M$57.06M39.14174CATXPerspective Therapeutics3.4368 of 5 stars$3.47-0.3%$15.14+336.4%N/A$234.53M$1.43M0.00116Positive NewsDRTSAlpha Tau Medical2.1157 of 5 stars$3.08+0.3%$8.00+159.7%+13.5%$215.37MN/A-7.1480News CoverageGap UpPROFProfound Medical2.6912 of 5 stars$7.13-3.6%$13.75+92.8%-23.9%$214.11M$7.20M-5.52150Analyst RevisionSKINBeauty Health1.7615 of 5 stars$1.59+0.3%$2.55+60.9%-43.5%$196.73M$398M-3.761,030Gap UpKRMDKORU Medical Systems1.448 of 5 stars$4.27-0.7%$4.13-3.4%+74.6%$195.74M$28.52M-17.2080SGHTSight Sciences3.3512 of 5 stars$3.68+2.8%$5.12+39.1%+8.7%$186.80M$81.06M-3.51210LAKELakeland Industries4.6273 of 5 stars$23.53+3.7%$26.50+12.6%+40.2%$174.26M$151.82M-252.221,750Options VolumeNews CoverageBWAYBrainsWay4.1767 of 5 stars$9.55+1.4%$13.17+37.9%+61.3%$159.28M$38.63M95.20120 Related Companies and Tools Related Companies Pulmonx Alternatives Electromed Alternatives Perspective Therapeutics Alternatives Alpha Tau Medical Alternatives Profound Medical Alternatives Beauty Health Alternatives KORU Medical Systems Alternatives Sight Sciences Alternatives Lakeland Industries Alternatives BrainsWay Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MLSS) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
